Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teng-Yu Lee

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Hepato-Gastroenterology|February 2, 2013
MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in FemalesTeng-Yu Lee, Cheng-Chan Yu, Cheng-Chung Wu, et al.
Digestive Diseases (Basel, Switzerland)|February 23, 2025
HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Shou-Wu Lee, Chun-Fang Tung, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2023
Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV InfectionHsin-Ju Tsai, Ming-Ju Wu, Cheng-Hsu Chen, et al.
Digestive Diseases (Basel, Switzerland)|May 2, 2024
Validating the Baveno Elastography Criteria of Advanced Liver Fibrosis in Two-Dimensional Shear Wave Elastography: A Prospective Pathology-Based StudyChia-Chang Chen, Yao-Kuang Huang, Ren-Ching Wang, et al.
World Journal of Oncology|November 10, 2025
Utility of Alpha-Fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II Kinetics in Predicting Radiologic Response and Survival in Unresectable Hepatocellular Carcinoma Undergoing ImmunotherapyShou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, et al.
JHEP Reports : Innovation in Hepatology|December 5, 2022
Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysisCheng-Hao Tseng, Tzu-Haw Chen, Jia-Ling Wu, et al.
Journal of Clinical Gastroenterology|February 22, 2013
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancerTeng-Yu Lee, Jaw-Town Lin, Cheng-Chung Wu, et al.
Journal of the Chinese Medical Association : JCMA|October 5, 2017
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-upYi-Jun Liao, Yen-Chang Li, Shou-Wu Lee, et al.
Journal of Clinical Medicine|August 7, 2021
Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse TherapyYing-Cheng Lin, Yen-Ju Chen, Shou-Wu Lee, et al.
Journal of Viral Hepatitis|December 2, 2017
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovirYao-Chun Hsu, Hsiu-J Ho, Teng-Yu Lee, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Hepato-Gastroenterology|February 2, 2013
MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in FemalesTeng-Yu Lee, Cheng-Chan Yu, Cheng-Chung Wu, et al.
Digestive Diseases (Basel, Switzerland)|February 23, 2025
HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Shou-Wu Lee, Chun-Fang Tung, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2023
Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV InfectionHsin-Ju Tsai, Ming-Ju Wu, Cheng-Hsu Chen, et al.
Digestive Diseases (Basel, Switzerland)|May 2, 2024
Validating the Baveno Elastography Criteria of Advanced Liver Fibrosis in Two-Dimensional Shear Wave Elastography: A Prospective Pathology-Based StudyChia-Chang Chen, Yao-Kuang Huang, Ren-Ching Wang, et al.
World Journal of Oncology|November 10, 2025
Utility of Alpha-Fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II Kinetics in Predicting Radiologic Response and Survival in Unresectable Hepatocellular Carcinoma Undergoing ImmunotherapyShou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, et al.
JHEP Reports : Innovation in Hepatology|December 5, 2022
Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysisCheng-Hao Tseng, Tzu-Haw Chen, Jia-Ling Wu, et al.
Journal of Clinical Gastroenterology|February 22, 2013
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancerTeng-Yu Lee, Jaw-Town Lin, Cheng-Chung Wu, et al.
Journal of the Chinese Medical Association : JCMA|October 5, 2017
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-upYi-Jun Liao, Yen-Chang Li, Shou-Wu Lee, et al.
Journal of Clinical Medicine|August 7, 2021
Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse TherapyYing-Cheng Lin, Yen-Ju Chen, Shou-Wu Lee, et al.
Journal of Viral Hepatitis|December 2, 2017
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovirYao-Chun Hsu, Hsiu-J Ho, Teng-Yu Lee, et al.
Pageof 13